Sequential Doxorubicin and Docetaxel as First-Line Treatment in Metastatic Breast Cancer: A GEICAM-9801 Phase II Study E. AlbaN. RibellesM.J. Godes OriginalPaper Pages: 1 - 8
Evaluation of Lymph Node Status in Male Breast Cancer Patients: A Role for Sentinel Lymph Node Biopsy* Daniel AlboFrederick C. AmesHenry M. Kuerer OriginalPaper Pages: 9 - 14
The Expression of Growth Hormone-Releasing Hormone (GHRH) and its Receptor Splice Variants in Human Breast Cancer Lines; The Evaluation of Signaling Mechanisms in the Stimulation of Cell Proliferation M. Olga Garcia-FernandezAndrew V. SchallyRebeca Busto OriginalPaper Pages: 15 - 26
Polymorphisms in Steroid Hormone Pathway Genes and Mammographic Density Christopher A. HaimanSusan E. HankinsonCelia Byrne OriginalPaper Pages: 27 - 36
Cell Proliferation, Apoptosis, and Expression of Bcl-2 and Bax in Non-Lactating Human Breast Epithelium in Relation to the Menstrual Cycle and Reproductive History F. FeuerhakeW. SiggU. Welsch OriginalPaper Pages: 37 - 48
Sex Hormone-Induced Mammary Carcinogenesis in Female Noble Rats: Detection of Differentially Expressed Genes G. LeungS.W. TsaoY.C. Wong OriginalPaper Pages: 49 - 63
Development and Characterization of a Progressive Series of Mammary Adenocarcinoma Cell Lines Derived from the C3(1)/SV40 Large T-antigen Transgenic Mouse Model Ryan G. HolzerChristina MacDougallCheryl L. Jorcyk OriginalPaper Pages: 65 - 76
The Prognostic Value of the Mitotic Activity Index in Patients with Primary Breast Cancer Who were not Treated with Adjuvant Systemic Therapy P. MandersP. BultL.V.A.M. Beex OriginalPaper Pages: 77 - 84
Matrix Metalloproteinase-2 (MMP-2) in T1–2N0 breast carcinoma Riikka HirvonenAnne Talvensaari-MattilaTaina Turpeenniemi-Hujanen OriginalPaper Pages: 85 - 91